Brachytherapy Afterloader System from Japan
High-dose rate brachytherapy device delivering Iridium-192 sources directly into tumors for precise radiation therapy. Used in nonprofit cancer centers for prostate and gynecological treatments. Qualifies under HTS 9810.00.80.00 as integral radioactive therapeutic apparatus.
Duty Rate — Japan → United States
10%
Rate breakdown
9903.03.0110%Except for products described in headings 9903.03.02–9903.03.11, articles the product of any country, as provided for in subdivision (aa) of U.S. note 2 to this subchapter
Import Tips
• Include NRC/AEC source material license and institutional radiation safety plan
• Document apparatus design confirming integral radioactive source delivery mechanism
• Maintain records proving exclusive therapeutic use in nonprofit institutions